Related Experiment Videos
[A case of thyroid metastasis from hypernephroma (author's transl)]
Tumori
|September 1, 1975
Abstract:
The literature on the subject is reviewed and a case of isolated thyroid metastasis from hypernephroma is presented. Although isolated metastases are very rare, the possibility of long survival justifies aggressive surgery.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Does nutrition for cancer patients feed the tumour? A clinical perspective.
Critical reviews in oncology/hematology·2020
Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
ESPEN expert group recommendations for action against cancer-related malnutrition.
Clinical nutrition (Edinburgh, Scotland)·2017
Defining malnutrition: A plea to rethink.
Clinical nutrition (Edinburgh, Scotland)·2016
European Society of Coloproctology consensus on the surgical management of intestinal failure in adults.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2016
Time to Treatment Failure as a Recorded Treatment-Process Measure in C-CAT. Reply to Comment on "Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462".
Current oncology (Toronto, Ont.)·2026
Does Time to Treatment Failure Measure the Same Clinical Process Across Oncology Facilities? Comment on Kajiura et al. Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462.
Current oncology (Toronto, Ont.)·2026
[177Lu]Lu-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer: Evidence from PSMAddition and Considerations for Treatment Sequencing.
Current oncology (Toronto, Ont.)·2026
A New Era of Treatment Sequencing in Platinum-Resistant Ovarian Cancer: Integrating Immunotherapy, Antibody-Drug Conjugates, and Targeted Therapies.
Current oncology (Toronto, Ont.)·2026